Medical technology company ENDRA has completed a round of private financing to provide financial support for its entry into the digital asset field, and will immediately allocate part of the funds to HYPE tokens - which will become a core component of its active asset pool management. According to news on October 23, the Ann Arbor-based medical technology company has completed a round of private equity financing (PIPE), with proceeds raised 4.90 million US dollars. Institutional investors and cr...
医疗科技公司ENDRA已完成一轮私募融资,为其进军数字资产领域提供资金支持,并立即将部分资金用于配置HYPE代币——该代币将成为其主动资产库管理的核心组成部分。根据10月23日消息,这家总部位于安阿伯市的医疗科技公司已完成一轮私募股权融资(PIPE),募集资金490万美元,机构投资者与加密领域投资者为此次融资的主要参与方。 与此同时...
ENDRA Life Sciences Inc. (NASDAQ: NDRA, "ENDRA" or "the Company") is a pioneer in imaging technology focused on the early detection and monitoring of metabolic dysfunction-associated liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). The company announced today that it has received a total of $4.90 million in private placement (...